Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

27. november 2017 oppdatert av: GlaxoSmithKline

A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus

The study will compare and evaluate the effects of long-term treatment of monotherapy with rosiglitazone, metformin and glyburide/glibenclamide on the improvement and maintenance of glycemic control in patients with recently diagnosed type 2 diabetes mellitus.

Studieoversikt

Status

Fullført

Forhold

Diabetes mellitus, type 2

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Faktiske)

4426

Fase

Fase 3

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

Belgia
- - Blankenberge, Belgia, 8370
    - GSK Investigational Site
  - Boechout, Belgia, 2530
    - GSK Investigational Site
  - Deurne, Belgia, 2100
    - GSK Investigational Site
  - Leuven, Belgia, 3000
    - GSK Investigational Site
  - Lubbeek (Linden), Belgia, B-3210
    - GSK Investigational Site
  - Tielt, Belgia, 8700
    - GSK Investigational Site
  - Wezembeek-Oppem, Belgia, 1970
    - GSK Investigational Site
  - Wijnegem, Belgia, 2110
    - GSK Investigational Site
  - Zemst, Belgia, 1980
    - GSK Investigational Site
Canada
- Alberta
  - Calgary, Alberta, Canada, T2R 0X7
    - GSK Investigational Site
  - Edmonton, Alberta, Canada, T6G 2C8
    - GSK Investigational Site
  - Edmonton, Alberta, Canada, T5N 3Y6
    - GSK Investigational Site
  - Red Deer, Alberta, Canada, T4N 6V7
    - GSK Investigational Site
- British Columbia
  - Coquitlam, British Columbia, Canada, V3K 3P4
    - GSK Investigational Site
  - Vancouver, British Columbia, Canada, V5Z 1M9
    - GSK Investigational Site
  - Victoria, British Columbia, Canada, V8R 6T9
    - GSK Investigational Site
- Manitoba
  - Winnipeg, Manitoba, Canada, R2H 2A6
    - GSK Investigational Site
  - Winnipeg, Manitoba, Canada, R3E 3P4
    - GSK Investigational Site
- New Brunswick
  - Cambellton, New Brunswick, Canada, E3N 3S8
    - GSK Investigational Site
  - Moncton, New Brunswick, Canada, E1C 6Z8
    - GSK Investigational Site
- Newfoundland and Labrador
  - Saint John's, Newfoundland and Labrador, Canada, A1B 3V6
    - GSK Investigational Site
- Nova Scotia
  - Antigonish, Nova Scotia, Canada, B2G 2C2
    - GSK Investigational Site
  - Halifax, Nova Scotia, Canada, B3H 1V7
    - GSK Investigational Site
- Ontario
  - Burlington, Ontario, Canada, L7M 4Y1
    - GSK Investigational Site
  - Kingston, Ontario, Canada, K7L 2V7
    - GSK Investigational Site
  - London, Ontario, Canada, N6A 4V2
    - GSK Investigational Site
  - Mississauga, Ontario, Canada, L5M 2N1
    - GSK Investigational Site
  - Oakville, Ontario, Canada, L6H 3P1
    - GSK Investigational Site
  - Ottawa, Ontario, Canada, K1H 7W9
    - GSK Investigational Site
  - Sudbury, Ontario, Canada, P3A 1Y8
    - GSK Investigational Site
  - Thornhill, Ontario, Canada, L4J 1V8
    - GSK Investigational Site
  - Thunder Bay, Ontario, Canada, P7B 2Z3
    - GSK Investigational Site
  - Timmins, Ontario, Canada, P4N 8P2
    - GSK Investigational Site
  - Toronto, Ontario, Canada, M5C 2T2
    - GSK Investigational Site
  - Windsor, Ontario, Canada, N8X 1K4
    - GSK Investigational Site
- Prince Edward Island
  - Charlottetown, Prince Edward Island, Canada, C1A 1L2
    - GSK Investigational Site
- Quebec
  - Chicoutimi, Quebec, Canada, G7H 5H6
    - GSK Investigational Site
  - La Malbaie, Quebec, Canada, G5A 1W7
    - GSK Investigational Site
  - Laval, Quebec, Canada, H7T 2P5
    - GSK Investigational Site
  - Montreal, Quebec, Canada, H1T 2M4
    - GSK Investigational Site
  - Montreal, Quebec, Canada, H2W 1T8
    - GSK Investigational Site
  - Plessisville, Quebec, Canada, G6L 3J1
    - GSK Investigational Site
  - Saint Marc Des Carrieres, Quebec, Canada, G0A 4B0
    - GSK Investigational Site
  - Sainte-Foy, Quebec, Canada, G1V 4G5
    - GSK Investigational Site
  - Sherbrooke, Quebec, Canada, J1H 5N4
    - GSK Investigational Site
  - St-Isidore De Dorchester, Quebec, Canada, G0S 2S0
    - GSK Investigational Site
- Saskatchewan
  - Regina, Saskatchewan, Canada, S4P 0W5
    - GSK Investigational Site
  - Saskatoon, Saskatchewan, Canada, S7N 0W8
    - GSK Investigational Site
Danmark
- - Frederiksberg C, Danmark, 1900
    - GSK Investigational Site
  - Odense, Danmark, 5000
    - GSK Investigational Site
Finland
- - Hanko, Finland, 10900
    - GSK Investigational Site
  - Helsinki, Finland, 00150
    - GSK Investigational Site
  - Jyvaskyla, Finland, 40100
    - GSK Investigational Site
  - Lmatra, Finland, 55800
    - GSK Investigational Site
  - Savitaipale, Finland, 54800
    - GSK Investigational Site
Forente stater
- Alabama
  - Anniston, Alabama, Forente stater, 36207
    - GSK Investigational Site
  - Birmingham, Alabama, Forente stater, 35233
    - GSK Investigational Site
- Arizona
  - Mesa, Arizona, Forente stater, 85206
    - GSK Investigational Site
  - Tucson, Arizona, Forente stater, 85723
    - GSK Investigational Site
- Arkansas
  - Little Rock, Arkansas, Forente stater, 77205
    - GSK Investigational Site
- California
  - Berkeley, California, Forente stater, 94705
    - GSK Investigational Site
  - Corona, California, Forente stater, 92879
    - GSK Investigational Site
  - Fair Oaks, California, Forente stater, 95628
    - GSK Investigational Site
  - Fremont, California, Forente stater, 94538
    - GSK Investigational Site
  - Fresno, California, Forente stater, 93720
    - GSK Investigational Site
  - Fullerton, California, Forente stater, 92835
    - GSK Investigational Site
  - Greenbrae, California, Forente stater, 94904
    - GSK Investigational Site
  - Harbor City, California, Forente stater, 90710
    - GSK Investigational Site
  - Healdsburg, California, Forente stater, 95448
    - GSK Investigational Site
  - La Jolla, California, Forente stater, 92037
    - GSK Investigational Site
  - Loma Linda, California, Forente stater, 92354
    - GSK Investigational Site
  - Los Angeles, California, Forente stater, 90095
    - GSK Investigational Site
  - Los Angeles, California, Forente stater, 90059
    - GSK Investigational Site
  - Modesto, California, Forente stater, 95355
    - GSK Investigational Site
  - Pasadena, California, Forente stater, 91105
    - GSK Investigational Site
  - San Diego, California, Forente stater, 92126
    - GSK Investigational Site
  - San Francisco, California, Forente stater, 94143
    - GSK Investigational Site
  - Santa Rosa, California, Forente stater, 95405
    - GSK Investigational Site
  - Sunnyvale, California, Forente stater, 94086
    - GSK Investigational Site
  - Ukiah, California, Forente stater, 95482
    - GSK Investigational Site
  - Walnut Creek, California, Forente stater, 94598
    - GSK Investigational Site
  - Yorba Linda, California, Forente stater, 92886
    - GSK Investigational Site
- Colorado
  - Boulder, Colorado, Forente stater, 80304
    - GSK Investigational Site
  - Denver, Colorado, Forente stater, 80209
    - GSK Investigational Site
  - Denver, Colorado, Forente stater, 80220
    - GSK Investigational Site
  - Englewood, Colorado, Forente stater, 80110
    - GSK Investigational Site
  - Longmont, Colorado, Forente stater, 80501
    - GSK Investigational Site
  - Wheat Ridge, Colorado, Forente stater, 80033
    - GSK Investigational Site
  - Wheat Ridge, Colorado, Forente stater, 80043
    - GSK Investigational Site
- District of Columbia
  - Washington, District of Columbia, Forente stater, 20037
    - GSK Investigational Site
  - Washington, District of Columbia, Forente stater, 20003
    - GSK Investigational Site
- Florida
  - Fort Myers, Florida, Forente stater, 33907
    - GSK Investigational Site
  - Hollywood, Florida, Forente stater, 33023
    - GSK Investigational Site
  - Jacksonville, Florida, Forente stater, 32216
    - GSK Investigational Site
  - Jacksonville, Florida, Forente stater, 32204
    - GSK Investigational Site
  - Melbourne, Florida, Forente stater, 32935
    - GSK Investigational Site
  - Miami, Florida, Forente stater, 33136
    - GSK Investigational Site
  - Miami, Florida, Forente stater, 33176
    - GSK Investigational Site
  - Orlando, Florida, Forente stater, 32806
    - GSK Investigational Site
  - Palm Harbor, Florida, Forente stater, 34683
    - GSK Investigational Site
  - Saint Petersburg, Florida, Forente stater, 33710
    - GSK Investigational Site
  - Saint Petersburg, Florida, Forente stater, 33702
    - GSK Investigational Site
  - Sarasota, Florida, Forente stater, 34239
    - GSK Investigational Site
  - Tampa, Florida, Forente stater, 33612
    - GSK Investigational Site
  - Titusville, Florida, Forente stater, 32796
    - GSK Investigational Site
  - West Palm Beach, Florida, Forente stater, 33401
    - GSK Investigational Site
- Georgia
  - Atlanta, Georgia, Forente stater, 30322
    - GSK Investigational Site
  - Atlanta, Georgia, Forente stater, 30312
    - GSK Investigational Site
  - Atlanta, Georgia, Forente stater, 30308
    - GSK Investigational Site
  - Atlanta, Georgia, Forente stater, 30338
    - GSK Investigational Site
  - Atlanta, Georgia, Forente stater, 30328
    - GSK Investigational Site
  - Blue Ridge, Georgia, Forente stater, 30513
    - GSK Investigational Site
  - Dunwoody, Georgia, Forente stater, 30338
    - GSK Investigational Site
  - Fayetteville, Georgia, Forente stater, 30214
    - GSK Investigational Site
- Hawaii
  - Honolulu, Hawaii, Forente stater, 96813
    - GSK Investigational Site
- Idaho
  - Boise, Idaho, Forente stater, 83706
    - GSK Investigational Site
- Illinois
  - Chicago, Illinois, Forente stater, 60612
    - GSK Investigational Site
  - Gurnee, Illinois, Forente stater, 60031
    - GSK Investigational Site
  - Springfield, Illinois, Forente stater, 62704
    - GSK Investigational Site
- Indiana
  - Evansville, Indiana, Forente stater, 47713
    - GSK Investigational Site
  - Indianapolis, Indiana, Forente stater, 46202
    - GSK Investigational Site
  - Indianapolis, Indiana, Forente stater, 46250
    - GSK Investigational Site
- Kentucky
  - Lexington, Kentucky, Forente stater, 40504-2681
    - GSK Investigational Site
- Louisiana
  - Lake Charles, Louisiana, Forente stater, 70601
    - GSK Investigational Site
  - New Orleans, Louisiana, Forente stater, 70119
    - GSK Investigational Site
  - Slidell, Louisiana, Forente stater, 70461
    - GSK Investigational Site
  - Slidell, Louisiana, Forente stater, 70458
    - GSK Investigational Site
- Maine
  - Bangor, Maine, Forente stater, 04401
    - GSK Investigational Site
- Maryland
  - Baltimore, Maryland, Forente stater, 21201
    - GSK Investigational Site
  - Baltimore, Maryland, Forente stater, 21208
    - GSK Investigational Site
  - Baltimore, Maryland, Forente stater, 21204
    - GSK Investigational Site
  - Baltimore, Maryland, Forente stater, 21205
    - GSK Investigational Site
- Massachusetts
  - Boston, Massachusetts, Forente stater, 02114
    - GSK Investigational Site
  - Springfield, Massachusetts, Forente stater, 01199
    - GSK Investigational Site
- Michigan
  - Ann Arbor, Michigan, Forente stater, 48109
    - GSK Investigational Site
  - Detroit, Michigan, Forente stater, 48201
    - GSK Investigational Site
  - Lansing, Michigan, Forente stater, 48912
    - GSK Investigational Site
  - Royal Oak, Michigan, Forente stater, 48073
    - GSK Investigational Site
- Minnesota
  - Minneapolis, Minnesota, Forente stater, 55404
    - GSK Investigational Site
  - Minneapolis, Minnesota, Forente stater, 55407-3799
    - GSK Investigational Site
  - Minneapolis, Minnesota, Forente stater, 55416
    - GSK Investigational Site
- Mississippi
  - Jackson, Mississippi, Forente stater, 39202
    - GSK Investigational Site
  - Olive Branch, Mississippi, Forente stater, 38654
    - GSK Investigational Site
- Missouri
  - Kansas City, Missouri, Forente stater, 64132
    - GSK Investigational Site
  - Saint Louis, Missouri, Forente stater, 63110
    - GSK Investigational Site
  - Saint Louis, Missouri, Forente stater, 63128
    - GSK Investigational Site
- Montana
  - Billings, Montana, Forente stater, 59102
    - GSK Investigational Site
- Nebraska
  - Omaha, Nebraska, Forente stater, 68131
    - GSK Investigational Site
  - Omaha, Nebraska, Forente stater, 68105
    - GSK Investigational Site
- Nevada
  - Henderson, Nevada, Forente stater, 89014
    - GSK Investigational Site
- New Jersey
  - Cherry Hill, New Jersey, Forente stater, 08034
    - GSK Investigational Site
  - Cherry Hill, New Jersey, Forente stater, 8034
    - GSK Investigational Site
- New Mexico
  - Albuquerque, New Mexico, Forente stater, 87106
    - GSK Investigational Site
  - Albuquerque, New Mexico, Forente stater, 87102
    - GSK Investigational Site
  - Albuquerque, New Mexico, Forente stater, 87109
    - GSK Investigational Site
- New York
  - Albany, New York, Forente stater, 12206
    - GSK Investigational Site
  - Bronx, New York, Forente stater, 10461
    - GSK Investigational Site
  - Endwell, New York, Forente stater, 13760
    - GSK Investigational Site
  - Flushing, New York, Forente stater, 11365
    - GSK Investigational Site
  - New York, New York, Forente stater, 10032
    - GSK Investigational Site
  - New York, New York, Forente stater, 10021
    - GSK Investigational Site
  - New York, New York, Forente stater, 10029
    - GSK Investigational Site
  - New York, New York, Forente stater, 10003
    - GSK Investigational Site
  - New York, New York, Forente stater, 10010
    - GSK Investigational Site
  - Rochester, New York, Forente stater, 14642
    - GSK Investigational Site
  - Rochester, New York, Forente stater, 14609
    - GSK Investigational Site
  - Syracuse, New York, Forente stater, 13210
    - GSK Investigational Site
- North Carolina
  - Durham, North Carolina, Forente stater, 27710
    - GSK Investigational Site
- Ohio
  - Cincinnati, Ohio, Forente stater, 45219
    - GSK Investigational Site
  - Cleveland, Ohio, Forente stater, 44195
    - GSK Investigational Site
  - Cleveland, Ohio, Forente stater, 44121
    - GSK Investigational Site
  - Mogadore, Ohio, Forente stater, 44260
    - GSK Investigational Site
  - Westlake, Ohio, Forente stater, 44145
    - GSK Investigational Site
- Oklahoma
  - Oklahoma City, Oklahoma, Forente stater, 73104
    - GSK Investigational Site
- Oregon
  - Bend, Oregon, Forente stater, 97701
    - GSK Investigational Site
  - Eugene, Oregon, Forente stater, 97401
    - GSK Investigational Site
  - Portland, Oregon, Forente stater, 97239
    - GSK Investigational Site
  - Portland, Oregon, Forente stater, 97219
    - GSK Investigational Site
- Pennsylvania
  - Downingtown, Pennsylvania, Forente stater, 19335
    - GSK Investigational Site
  - Feasterville, Pennsylvania, Forente stater, 19053
    - GSK Investigational Site
  - Fleetwood, Pennsylvania, Forente stater, 19522
    - GSK Investigational Site
  - Hermitage, Pennsylvania, Forente stater, 16148
    - GSK Investigational Site
  - Hershey, Pennsylvania, Forente stater, 17033
    - GSK Investigational Site
  - Jefferson Hills, Pennsylvania, Forente stater, 15025
    - GSK Investigational Site
  - Philadelphia, Pennsylvania, Forente stater, 19107
    - GSK Investigational Site
  - Philadelphia, Pennsylvania, Forente stater, 19104
    - GSK Investigational Site
  - Philadelphia, Pennsylvania, Forente stater, 19115
    - GSK Investigational Site
  - Philadelphia, Pennsylvania, Forente stater, 19148
    - GSK Investigational Site
  - Pittsburgh, Pennsylvania, Forente stater, 15219
    - GSK Investigational Site
  - Upland, Pennsylvania, Forente stater, 19013
    - GSK Investigational Site
  - Warminster, Pennsylvania, Forente stater, 18974
    - GSK Investigational Site
  - West Chester, Pennsylvania, Forente stater, 19380
    - GSK Investigational Site
- South Carolina
  - Charleston, South Carolina, Forente stater, 29403
    - GSK Investigational Site
  - Columbia, South Carolina, Forente stater, 29201
    - GSK Investigational Site
  - Greer, South Carolina, Forente stater, 29651
    - GSK Investigational Site
  - Spartanburg, South Carolina, Forente stater, 29303
    - GSK Investigational Site
- Tennessee
  - Bristol, Tennessee, Forente stater, 37620
    - GSK Investigational Site
  - Nashville, Tennessee, Forente stater, 37211
    - GSK Investigational Site
- Texas
  - Arlington, Texas, Forente stater, 76014
    - GSK Investigational Site
  - Austin, Texas, Forente stater, 78745
    - GSK Investigational Site
  - Beaumont, Texas, Forente stater, 77701
    - GSK Investigational Site
  - Corpus Christi, Texas, Forente stater, 78412
    - GSK Investigational Site
  - Corpus Christi, Texas, Forente stater, 78411
    - GSK Investigational Site
  - Dallas, Texas, Forente stater, 75230
    - GSK Investigational Site
  - Dallas, Texas, Forente stater, 75231
    - GSK Investigational Site
  - Dallas, Texas, Forente stater, 75390
    - GSK Investigational Site
  - Fort Worth, Texas, Forente stater, 76107
    - GSK Investigational Site
  - Houston, Texas, Forente stater, 77030
    - GSK Investigational Site
  - Houston, Texas, Forente stater, 77024
    - GSK Investigational Site
  - Irving, Texas, Forente stater, 75061
    - GSK Investigational Site
  - Midland, Texas, Forente stater, 79705
    - GSK Investigational Site
  - San Antonio, Texas, Forente stater, 78229
    - GSK Investigational Site
  - San Antonio, Texas, Forente stater, 78207
    - GSK Investigational Site
- Utah
  - Ogden, Utah, Forente stater, 84403
    - GSK Investigational Site
  - Salt Lake City, Utah, Forente stater, 84103
    - GSK Investigational Site
  - Salt Lake City, Utah, Forente stater, 84108
    - GSK Investigational Site
- Virginia
  - Charlottesville, Virginia, Forente stater, 22908
    - GSK Investigational Site
  - Newport News, Virginia, Forente stater, 23606
    - GSK Investigational Site
  - Richmond, Virginia, Forente stater, 23249
    - GSK Investigational Site
  - Salem, Virginia, Forente stater, 24153
    - GSK Investigational Site
- Washington
  - Federal Way, Washington, Forente stater, 98003
    - GSK Investigational Site
  - Seattle, Washington, Forente stater, 98195
    - GSK Investigational Site
  - Seattle, Washington, Forente stater, 98108
    - GSK Investigational Site
  - Seattle, Washington, Forente stater, 98104
    - GSK Investigational Site
  - Spokane, Washington, Forente stater, 99204
    - GSK Investigational Site
  - Spokane, Washington, Forente stater, 99208
    - GSK Investigational Site
  - Spokane, Washington, Forente stater, 99207
    - GSK Investigational Site
  - Wenatchee, Washington, Forente stater, 98801
    - GSK Investigational Site
- West Virginia
  - Charleston, West Virginia, Forente stater, 25304
    - GSK Investigational Site
  - Huntington, West Virginia, Forente stater, 25701
    - GSK Investigational Site
- Wisconsin
  - Madison, Wisconsin, Forente stater, 53717
    - GSK Investigational Site
  - Milwaukee, Wisconsin, Forente stater, 53209
    - GSK Investigational Site
  - Oregon, Wisconsin, Forente stater, 53575
    - GSK Investigational Site
Frankrike
- - Alben, Frankrike, 73410
    - GSK Investigational Site
  - Bezier, Frankrike, 34500
    - GSK Investigational Site
  - Bourges, Frankrike, 18000
    - GSK Investigational Site
  - Brogile, Frankrike, 27270
    - GSK Investigational Site
  - Chartres, Frankrike, 28000
    - GSK Investigational Site
  - Denguin, Frankrike, 64230
    - GSK Investigational Site
  - Evreux, Frankrike, 27000
    - GSK Investigational Site
  - Gamarde Les Bains, Frankrike, 40380
    - GSK Investigational Site
  - La Rochelle, Frankrike, 17000
    - GSK Investigational Site
  - Labarthe Sur Leze, Frankrike, 31860
    - GSK Investigational Site
  - Le Mans, Frankrike, 72000
    - GSK Investigational Site
  - Le Pian Medoc, Frankrike, 33290
    - GSK Investigational Site
  - Lille, Frankrike, 59000
    - GSK Investigational Site
  - Mallemort, Frankrike, 13370
    - GSK Investigational Site
  - Marseille, Frankrike, 13008
    - GSK Investigational Site
  - Marseille, Frankrike, 13001
    - GSK Investigational Site
  - Marsillargues, Frankrike, 34590
    - GSK Investigational Site
  - Marssac, Frankrike, 81150
    - GSK Investigational Site
  - Mont De Marsen, Frankrike, 40000
    - GSK Investigational Site
  - Montignac, Frankrike, 24290
    - GSK Investigational Site
  - Moulon, Frankrike, 33420
    - GSK Investigational Site
  - Murs Erigne, Frankrike, 49610
    - GSK Investigational Site
  - Nantes, Frankrike, 44300
    - GSK Investigational Site
  - Nantes Cedex 01, Frankrike, 44093
    - GSK Investigational Site
  - Nimes, Frankrike, 30900
    - GSK Investigational Site
  - Orthez, Frankrike, 64300
    - GSK Investigational Site
  - Paris, Frankrike, 75015
    - GSK Investigational Site
  - Rennes, Frankrike, 35200
    - GSK Investigational Site
  - Roanna, Frankrike, 42300
    - GSK Investigational Site
  - Saint Etienne, Frankrike, 42000
    - GSK Investigational Site
  - Saint Genies Des Fontaines, Frankrike, 66740
    - GSK Investigational Site
  - Sisteron, Frankrike, 04200
    - GSK Investigational Site
  - St Julien Des Landes, Frankrike, 85150
    - GSK Investigational Site
  - St Martin D'Heres, Frankrike, 38400
    - GSK Investigational Site
  - St Pierre de Chandieu, Frankrike, 69780
    - GSK Investigational Site
  - Strasbourg, Frankrike, 67000
    - GSK Investigational Site
  - Tarare, Frankrike, 69170
    - GSK Investigational Site
  - Vieux Conde, Frankrike, 59690
    - GSK Investigational Site
  - Vourey, Frankrike, 38210
    - GSK Investigational Site
Irland
- - Belfast, Irland, BT16 ORH
    - GSK Investigational Site
  - Co. Tipperary, Irland
    - GSK Investigational Site
  - Cork, Irland
    - GSK Investigational Site
  - Dublin, Irland, 8
    - GSK Investigational Site
  - Dublin, Irland, 4
    - GSK Investigational Site
  - Dublin, Irland, 7
    - GSK Investigational Site
  - Dublin, Irland, 15
    - GSK Investigational Site
  - Dublin, Irland, 24
    - GSK Investigational Site
  - Gowran, Irland
    - GSK Investigational Site
  - Kilkenny, Irland
    - GSK Investigational Site
Italia
- - Firenze, Italia, 50134
    - GSK Investigational Site
  - La Spezia, Italia, 19100
    - GSK Investigational Site
  - Lecce, Italia, 73100
    - GSK Investigational Site
  - Milano, Italia, 20132
    - GSK Investigational Site
  - Palermo, Italia, 90127
    - GSK Investigational Site
  - Parma, Italia, 43100
    - GSK Investigational Site
  - Perugia, Italia, 06126
    - GSK Investigational Site
  - Rovigo, Italia, 45100
    - GSK Investigational Site
  - S. Benedetto TR (AP), Italia
    - GSK Investigational Site
  - San Giovanni Rotondo FG, Italia
    - GSK Investigational Site
  - Sassari, Italia
    - GSK Investigational Site
  - Terni, Italia, 05100
    - GSK Investigational Site
  - Torino, Italia, 10126
    - GSK Investigational Site
  - Udine, Italia, 33100
    - GSK Investigational Site
  - Vicenza, Italia, 36100
    - GSK Investigational Site
- Emilia-Romagna
  - Ferrara, Emilia-Romagna, Italia, 44100
    - GSK Investigational Site
  - Ravenna, Emilia-Romagna, Italia, 48100
    - GSK Investigational Site
  - Scandiano (RE), Emilia-Romagna, Italia, 42019
    - GSK Investigational Site
- Lombardia
  - Rozzano (MI), Lombardia, Italia, 20089
    - GSK Investigational Site
- Puglia
  - Acquaviva Delle Fonti (BA), Puglia, Italia, 70021
    - GSK Investigational Site
- Sicilia
  - Catania, Sicilia, Italia, 95100
    - GSK Investigational Site
- Umbria
  - Città Di Castello (PG), Umbria, Italia, 06012
    - GSK Investigational Site
Nederland
- - De Bilt, Nederland, 3731 DN
    - GSK Investigational Site
  - Den Bosch, Nederland, 5223 GV
    - GSK Investigational Site
  - Geleen, Nederland, 6166 GR
    - GSK Investigational Site
  - Hengelo, Nederland, 7555 DL
    - GSK Investigational Site
  - Huizen, Nederland, 1271 BB
    - GSK Investigational Site
  - Losser, Nederland, 7581 BV
    - GSK Investigational Site
  - Losser, Nederland, 7582 BD
    - GSK Investigational Site
  - Rijswijk, Nederland, 2281 AK
    - GSK Investigational Site
  - Roelofarendsveen, Nederland, 2371 RB
    - GSK Investigational Site
  - Woerden, Nederland, 3443 GG
    - GSK Investigational Site
Norge
- - Hamar, Norge, 2317
    - GSK Investigational Site
  - Paradis, Norge, 5231
    - GSK Investigational Site
  - Skedsmokorset, Norge, N-2020
    - GSK Investigational Site
Spania
- - Albaida (Valencia), Spania
    - GSK Investigational Site
  - Basurto/Bilbao, Spania, 48013
    - GSK Investigational Site
  - Benassal (Castellón), Spania, 12160
    - GSK Investigational Site
  - Benicasim (Castellón), Spania
    - GSK Investigational Site
  - Bilbao, Spania, 48013
    - GSK Investigational Site
  - Cartagena, Spania, 30203
    - GSK Investigational Site
  - Cáceres, Spania, 10005
    - GSK Investigational Site
  - El Palmar (Murcia), Spania, 30120
    - GSK Investigational Site
  - Elche (Alicante), Spania, 03202
    - GSK Investigational Site
  - Elda-Alicante, Spania, 03600
    - GSK Investigational Site
  - Figueras, Spania, 17600
    - GSK Investigational Site
  - Gerona, Spania
    - GSK Investigational Site
  - Granollers (Barcelona), Spania, 08400
    - GSK Investigational Site
  - Jerez (Cadiz), Spania, 11047
    - GSK Investigational Site
  - Madrid, Spania, 28006
    - GSK Investigational Site
  - Madrid, Spania, 28046
    - GSK Investigational Site
  - Malaga, Spania, 29009
    - GSK Investigational Site
  - Mataro, Spania, 08034
    - GSK Investigational Site
  - Merida, Spania, 6800
    - GSK Investigational Site
  - Olleria, Valencia, Spania, 46850
    - GSK Investigational Site
  - Onda/Castellón, Spania, 12200
    - GSK Investigational Site
  - Orihuela (Alicante), Spania, 03314
    - GSK Investigational Site
  - Plasencia, Spania, 10600
    - GSK Investigational Site
  - Pontevedra, Spania, 36071
    - GSK Investigational Site
  - Sagunto/Valencia, Spania, 46520
    - GSK Investigational Site
  - San Juan (Alicante), Spania, 03550
    - GSK Investigational Site
  - San Vincente Raspeig (Alicante), Spania, 03690
    - GSK Investigational Site
  - Santa Coloma De Gramanet (Barcelona), Spania, 08923
    - GSK Investigational Site
  - Tenerife, Spania, 38010
    - GSK Investigational Site
  - Tereul, Spania, 44002
    - GSK Investigational Site
  - Toledo, Spania, 45004
    - GSK Investigational Site
  - Torrelavega/Santander, Spania, 39300
    - GSK Investigational Site
  - Valencia, Spania, 46017
    - GSK Investigational Site
  - Valencia, Spania
    - GSK Investigational Site
  - Valencia, Spania, 46830
    - GSK Investigational Site
  - Valladolid, Spania, 47010
    - GSK Investigational Site
  - Vallda (Valencia), Spania
    - GSK Investigational Site
  - Villajoyosa - Alicante, Spania, 03570
    - GSK Investigational Site
  - Zamora, Spania, 49021
    - GSK Investigational Site
  - Zaragoza, Spania, 50003
    - GSK Investigational Site
Storbritannia
- - Barnsley, Storbritannia, S70 3RJ
    - GSK Investigational Site
  - Bath, Storbritannia, BA2 3HT
    - GSK Investigational Site
  - Bradford, Storbritannia, BD7 3EE
    - GSK Investigational Site
  - Cardiff, Storbritannia, CF5 4AE
    - GSK Investigational Site
  - Co.Antrim, Storbritannia
    - GSK Investigational Site
  - Doncaster, Storbritannia, DN1 2EG
    - GSK Investigational Site
  - Doncaster, Storbritannia, DN9 1EP
    - GSK Investigational Site
  - Gateshead, Storbritannia, NE9 6SX
    - GSK Investigational Site
  - Glasgow, Storbritannia, G51 4TF
    - GSK Investigational Site
  - Glenrothes, Storbritannia
    - GSK Investigational Site
  - Irvine, Storbritannia, KA12 OAY
    - GSK Investigational Site
  - Kent, Storbritannia, TN11 9HL
    - GSK Investigational Site
  - Leicester, Storbritannia, LE3 8GS
    - GSK Investigational Site
  - London, Storbritannia, SE1 9RT
    - GSK Investigational Site
  - London, Storbritannia, W1M 7AB
    - GSK Investigational Site
  - Newtownabbey, Storbritannia, BT36 4PP
    - GSK Investigational Site
  - Peterborough, Storbritannia, PE7 3JL
    - GSK Investigational Site
  - Swansea, Storbritannia, SA4 4BY
    - GSK Investigational Site
  - Wakefield, Storbritannia, WF1 4DG
    - GSK Investigational Site
  - Wigan, Storbritannia, WN1 1XX
    - GSK Investigational Site
- Aberdeenshire
  - Aberdeen, Aberdeenshire, Storbritannia, AB25 2AY
    - GSK Investigational Site
- Bedfordshire
  - Sandy, Bedfordshire, Storbritannia, SG19 3JR
    - GSK Investigational Site
- Berkshire
  - Reading, Berkshire, Storbritannia, RG2 7AG
    - GSK Investigational Site
- Carmarthenshire
  - Llanelli, Carmarthenshire, Storbritannia, SA14 8QF
    - GSK Investigational Site
- Cheshire
  - Warrington, Cheshire, Storbritannia, WA5 1QC
    - GSK Investigational Site
- Dorset
  - Bournemouth, Dorset, Storbritannia, BH7 7DW
    - GSK Investigational Site
  - Poole, Dorset, Storbritannia
    - GSK Investigational Site
- Glamorgan
  - Barry, Glamorgan, Storbritannia, CF63 4HP
    - GSK Investigational Site
  - Cardiff, Glamorgan, Storbritannia, CF14 9BB
    - GSK Investigational Site
- Hertfordshire
  - Hemel Hempstead, Hertfordshire, Storbritannia, HP2 4AD
    - GSK Investigational Site
  - Stevenage, Hertfordshire, Storbritannia
    - GSK Investigational Site
- Lanarkshire
  - Airdrie, Lanarkshire, Storbritannia, ML6 0JS
    - GSK Investigational Site
  - Glasgow, Lanarkshire, Storbritannia, G81 4SA
    - GSK Investigational Site
- Lancashire
  - Bolton, Lancashire, Storbritannia
    - GSK Investigational Site
  - Chorley, Lancashire, Storbritannia, PR7 1NY
    - GSK Investigational Site
- Midlothian
  - Edinburgh, Midlothian, Storbritannia, EH3 9YW
    - GSK Investigational Site
- Northamptonshire
  - Wellingborough, Northamptonshire, Storbritannia, NN8 4RW
    - GSK Investigational Site
- Nottinghamshire
  - Nottingham, Nottinghamshire, Storbritannia, NG3 7DQ
    - GSK Investigational Site
- Pembrokeshire
  - Haverfordwest, Pembrokeshire, Storbritannia, SA61 1RN
    - GSK Investigational Site
- Somerset
  - Frome, Somerset, Storbritannia, BA11 1EZ
    - GSK Investigational Site
- Sussex West
  - Crawley, Sussex West, Storbritannia, RH10 1LL
    - GSK Investigational Site
- Warwickshire
  - Nuneaton, Warwickshire, Storbritannia, CV10 7DJ
    - GSK Investigational Site
  - Rugby, Warwickshire, Storbritannia, CV21 3SP
    - GSK Investigational Site
- West Lothian
  - Livingston, West Lothian, Storbritannia, EH54 6PP
    - GSK Investigational Site
- Wiltshire
  - Melksham, Wiltshire, Storbritannia, SN12 6UN
    - GSK Investigational Site
  - Trowbridge, Wiltshire, Storbritannia, BA14 8TG
    - GSK Investigational Site
Sverige
- - Alta, Sverige, 138 21
    - GSK Investigational Site
  - Degerberga, Sverige, 297 31
    - GSK Investigational Site
  - Gimo, Sverige, SE-747 43
    - GSK Investigational Site
  - Malmö, Sverige, SE-214 26
    - GSK Investigational Site
  - Stockholm, Sverige, SE-114 35
    - GSK Investigational Site
Tsjekkia
- - Ostrava, Tsjekkia, 703 52
    - GSK Investigational Site
  - Phaha 5, Tsjekkia, 150 06
    - GSK Investigational Site
  - Praha 4, Tsjekkia, 142 00
    - GSK Investigational Site
  - Usti Nad Labem, Tsjekkia, 401 13
    - GSK Investigational Site
  - Zlin, Tsjekkia, 762 75
    - GSK Investigational Site
Tyskland
- - Berlin, Tyskland, 13355
    - GSK Investigational Site
  - Berlin, Tyskland, 13057
    - GSK Investigational Site
  - Hamburg, Tyskland, 22041
    - GSK Investigational Site
  - Hamburg, Tyskland, 22607
    - GSK Investigational Site
- Baden-Wuerttemberg
  - Bad Rappenau, Baden-Wuerttemberg, Tyskland, 74906
    - GSK Investigational Site
  - Deggingen, Baden-Wuerttemberg, Tyskland, 73326
    - GSK Investigational Site
  - Mannheim, Baden-Wuerttemberg, Tyskland, 68161
    - GSK Investigational Site
  - Trochtelfingen, Baden-Wuerttemberg, Tyskland, 72818
    - GSK Investigational Site
  - Unterschneidheim, Baden-Wuerttemberg, Tyskland, 73485
    - GSK Investigational Site
  - Wangen, Baden-Wuerttemberg, Tyskland, 88239
    - GSK Investigational Site
  - Weinheim, Baden-Wuerttemberg, Tyskland, 69469
    - GSK Investigational Site
- Bayern
  - Aschaffenburg, Bayern, Tyskland, 63739
    - GSK Investigational Site
  - Haag, Bayern, Tyskland, 83527
    - GSK Investigational Site
  - Hoehenkirchen-Siegertsbrunn, Bayern, Tyskland, 85635
    - GSK Investigational Site
  - Ismaning, Bayern, Tyskland, 85737
    - GSK Investigational Site
  - Krummenaab, Bayern, Tyskland, 92703
    - GSK Investigational Site
  - Kuenzing, Bayern, Tyskland, 94550
    - GSK Investigational Site
  - Landshut, Bayern, Tyskland, 84028
    - GSK Investigational Site
  - Muenchen, Bayern, Tyskland, 80339
    - GSK Investigational Site
  - Muenchen, Bayern, Tyskland, 80805
    - GSK Investigational Site
  - Muenchen, Bayern, Tyskland, 80469
    - GSK Investigational Site
  - Muenchen, Bayern, Tyskland, 80807
    - GSK Investigational Site
  - Muenchen, Bayern, Tyskland, 80937
    - GSK Investigational Site
  - Muenchen, Bayern, Tyskland, 81379
    - GSK Investigational Site
  - Nuernberg, Bayern, Tyskland, 90427
    - GSK Investigational Site
  - Wallerfing, Bayern, Tyskland, 94574
    - GSK Investigational Site
- Hessen
  - Bad Kreuznach, Hessen, Tyskland, 55545
    - GSK Investigational Site
  - Frankfurt, Hessen, Tyskland, 60326
    - GSK Investigational Site
  - Grossalmerode, Hessen, Tyskland, 37247
    - GSK Investigational Site
  - Lollar, Hessen, Tyskland, 35475
    - GSK Investigational Site
  - Offenbach, Hessen, Tyskland, 63071
    - GSK Investigational Site
  - Offenbach, Hessen, Tyskland, 63067
    - GSK Investigational Site
  - Offenbach, Hessen, Tyskland, 63065
    - GSK Investigational Site
  - Offenbach, Hessen, Tyskland, 63073
    - GSK Investigational Site
  - Schaafheim, Hessen, Tyskland, 64850
    - GSK Investigational Site
  - Vellmar, Hessen, Tyskland, 34246
    - GSK Investigational Site
- Niedersachsen
  - Damme, Niedersachsen, Tyskland, 49401
    - GSK Investigational Site
  - Hannover, Niedersachsen, Tyskland, 30171
    - GSK Investigational Site
  - Hannover, Niedersachsen, Tyskland, 30177
    - GSK Investigational Site
  - Hildesheim, Niedersachsen, Tyskland, 31139
    - GSK Investigational Site
  - Lueneburg, Niedersachsen, Tyskland, 21335
    - GSK Investigational Site
  - Paderborn, Niedersachsen, Tyskland, 33100
    - GSK Investigational Site
  - Winsen/Lohe, Niedersachsen, Tyskland, 21423
    - GSK Investigational Site
- Nordrhein-Westfalen
  - Beckum, Nordrhein-Westfalen, Tyskland, 59269
    - GSK Investigational Site
  - Bergkamen, Nordrhein-Westfalen, Tyskland, 59192
    - GSK Investigational Site
  - Borken, Nordrhein-Westfalen, Tyskland, 46325
    - GSK Investigational Site
  - Dortmund, Nordrhein-Westfalen, Tyskland, 44137
    - GSK Investigational Site
  - Duisburg, Nordrhein-Westfalen, Tyskland, 47119
    - GSK Investigational Site
  - Essen, Nordrhein-Westfalen, Tyskland, 45130
    - GSK Investigational Site
  - Euskirchen, Nordrhein-Westfalen, Tyskland, 53879
    - GSK Investigational Site
  - Goch, Nordrhein-Westfalen, Tyskland, 47574
    - GSK Investigational Site
  - Luedenscheid, Nordrhein-Westfalen, Tyskland, 58511
    - GSK Investigational Site
  - Luenen, Nordrhein-Westfalen, Tyskland, 44534
    - GSK Investigational Site
  - Neuss, Nordrhein-Westfalen, Tyskland, 41460
    - GSK Investigational Site
  - Schwabenheim, Nordrhein-Westfalen, Tyskland, 55270
    - GSK Investigational Site
  - Siegen, Nordrhein-Westfalen, Tyskland, 57072
    - GSK Investigational Site
  - Warendorf, Nordrhein-Westfalen, Tyskland, 48231
    - GSK Investigational Site
- Rheinland-Pfalz
  - Deidesheim, Rheinland-Pfalz, Tyskland, 67146
    - GSK Investigational Site
  - Diez, Rheinland-Pfalz, Tyskland, 65582
    - GSK Investigational Site
  - Lambrecht, Rheinland-Pfalz, Tyskland, 67466
    - GSK Investigational Site
  - Rhaunen, Rheinland-Pfalz, Tyskland, 55624
    - GSK Investigational Site
- Sachsen
  - Chemnitz, Sachsen, Tyskland, 09130
    - GSK Investigational Site
  - Dresden, Sachsen, Tyskland, 01309
    - GSK Investigational Site
  - Dresden, Sachsen, Tyskland, 01129
    - GSK Investigational Site
  - Dresden, Sachsen, Tyskland, 01187
    - GSK Investigational Site
  - Freital, Sachsen, Tyskland, 01705
    - GSK Investigational Site
  - Pirna, Sachsen, Tyskland, 01796
    - GSK Investigational Site
  - Schmiedeberg, Sachsen, Tyskland, 01762
    - GSK Investigational Site
- Schleswig-Holstein
  - Itzehoe, Schleswig-Holstein, Tyskland, 25524
    - GSK Investigational Site
  - Ratzeburg, Schleswig-Holstein, Tyskland, 23909
    - GSK Investigational Site
  - Wahlstedt, Schleswig-Holstein, Tyskland, 23812
    - GSK Investigational Site
  - Wilster, Schleswig-Holstein, Tyskland, 25554
    - GSK Investigational Site
Ungarn
- - Budapest, Ungarn, 1076
    - GSK Investigational Site
  - Miskolc, Ungarn, 3526
    - GSK Investigational Site
Østerrike
- - Vienna, Østerrike, A-1130
    - GSK Investigational Site
  - Vienna, Østerrike, A-1080
    - GSK Investigational Site
  - Wiener Neustadt, Østerrike, A-2700
    - GSK Investigational Site

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

30 år til 75 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion criteria:

Newly diagnosed patients (< 3years) with type 2 diabetes.
Fasting plasma glucose (FPG) range of 126-240 mg/dL at Screening.
No previous treatment with oral or parenteral glucose-lowering therapy.

Exclusion criteria:

History of lactic acidosis.
Anemia (<11g for males, <10 g for females).
Unstable or severe NY Heart Association-class 3 or 4.
Any NY Heart Association congestive heart failure.
Patients with chronic diseases requiring periodic or intermittent treatment with oral or intravenous corticosteroids.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Primært formål: Behandling
Tildeling: Randomisert
Intervensjonsmodell: Parallell tildeling

Hva måler studien?

Primære resultatmål

Resultatmål
Time from randomization to the primary action point (monotherapy failure).

Sekundære resultatmål

Resultatmål
Comparison of effects of long-term treatment with Rosiglitazone, Metformin, Glyburide: - maintenance/restoration of beta-cell function: HOMA IS, progression of microalbuminuria, fibrinolytic markers (PAI-1,fibrinogen, CRP).

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

GlaxoSmithKline

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Hjelpsomme linker

Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

3. januar 2000

Primær fullføring (Faktiske)

1. juni 2006

Studiet fullført (Faktiske)

19. juni 2006

Datoer for studieregistrering

Først innsendt

17. januar 2006

Først innsendt som oppfylte QC-kriteriene

17. januar 2006

Først lagt ut (Anslag)

19. januar 2006

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

29. november 2017

Siste oppdatering sendt inn som oppfylte QC-kriteriene

27. november 2017

Sist bekreftet

1. november 2017

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

type 2 diabetes monotherapy treatment naive

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

49653/048

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

IPD-planbeskrivelse

Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.

Studiedata/dokumenter

Skjema for informert samtykke
Informasjonsidentifikator: 49653/048

Informasjonskommentarer: For additional information about this study please refer to the GSK Clinical Study Register
Statistisk analyseplan
Informasjonsidentifikator: 49653/048

Informasjonskommentarer: For additional information about this study please refer to the GSK Clinical Study Register
Studieprotokoll
Informasjonsidentifikator: 49653/048

Informasjonskommentarer: For additional information about this study please refer to the GSK Clinical Study Register
Klinisk studierapport
Informasjonsidentifikator: 49653/048

Informasjonskommentarer: For additional information about this study please refer to the GSK Clinical Study Register
Datasett for individuell deltaker
Informasjonsidentifikator: 49653/048

Informasjonskommentarer: For additional information about this study please refer to the GSK Clinical Study Register
Datasettspesifikasjon
Informasjonsidentifikator: 49653/048

Informasjonskommentarer: For additional information about this study please refer to the GSK Clinical Study Register
Annotert saksrapportskjema
Informasjonsidentifikator: 49653/048

Informasjonskommentarer: For additional information about this study please refer to the GSK Clinical Study Register

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Diabetes mellitus, type 2

University Hospital Inselspital, Berne

Fullført

Evaluering av glykemisk kontroll ved bruk av GlucoTab® med insulin degludec hos sykehusinnlagte pasienter med diabetes mellitus type 2

Type 2 diabetes mellitus

Sveits
India Diabetes Research Foundation & Dr. A. Ramachandran...

Fullført

En klinisk studie for å studere effekten av to legemidler, Vildagliptin og Metformin hos pasienter med type 2 diabetes mellitus

TYPE 2 diabetes mellitus

India
US Department of Veterans Affairs
American Diabetes Association

Fullført

Correlation of Plasma Endothelial Cell Activity With Cardiovascular Events in Patients With Diabetes Mellitus Type 2

Type 2 diabetes mellitus

Forente stater
Dexa Medica Group

Fullført

Effekt og sikkerhet ved tilleggsterapi med DLBS3233 hos pasienter med type 2 diabetes mellitus

Type-2 diabetes mellitus

Indonesia
AstraZeneca

Rekruttering

Effekten av FDC-regime av Dapagliflozin/Metformin sammenlignet med samtidig administrert dobbel terapi på glykemisk kontroll, tilfredshet og overholdelse hos kinesiske pasienter med T2DM

Type 2 diabetes mellitus (T2DM)

Kina
Daewoong Pharmaceutical Co. LTD.

Har ikke rekruttert ennå

Studie for å evaluere langsiktig sikkerhet og effekt av DWP16001 hos pasienter med type 2 diabetes mellitus

T2DM (type 2 diabetes mellitus)
Zhongda Hospital

Rekruttering

Endovaskulær denervering (EDN) for behandling av type 2 diabetes mellitus

Type 2 diabetes mellitus (T2DM)

Kina
Newsoara Biopharma Co., Ltd.

Rekruttering

Sikkerhet, toleranse og farmakokinetikk av THR-1442 hos friske kinesiske personer

T2DM (type 2 diabetes mellitus)

Kina
Shanghai Golden Leaf MedTec Co. Ltd

Aktiv, ikke rekrutterende

Endovaskulær denervering for behandling av type 2 diabetes mellitus

Type 2 diabetes mellitus (T2DM)

Kina
Sanofi

Fullført

En studie av en eksisterende database for å vurdere behandlingens persistens for basal insulin hos pasienter med type 2 diabetes mellitus i et strukturert pasientopplæringsprogram i India (PERSISTENT)

Type 2 diabetes mellitus (T2DM)

Frankrike

Kliniske studier på metformin

Anji Pharma

Suspendert

Undersøkende studie av metformin med forsinket frigjøring (DREAM-T2D)

Diabetes mellitus, type 2

Spania, Forente stater, Canada, Ungarn, Brasil, Tsjekkia, Polen, Bulgaria
NuSirt Biopharma

Fullført

En utvidelsesprotokoll for å evaluere dosesammenligninger av leucin-metformin-kombinasjoner hos type 2-diabetespasienter

Type 2 diabetes mellitus

Forente stater
Shionogi

Fullført

Studie for å vurdere sikkerhet og farmakokinetikk til dobbeltblind S-707106 alene og i kombinasjon med åpen metformin hos pasienter med type 2 diabetes mellitus

Type 2 diabetes mellitus

Forente stater
Bristol-Myers Squibb

Fullført

Fase 4: Undersøkende studie for å evaluere metformin XR monoterapi versus metformin IR monoterapi hos pasienter med type 2 diabetes

Type 2 diabetes mellitus

Sør-Afrika, Forente stater, Canada, Puerto Rico, Ungarn, Tyskland, Tsjekkia, Polen, Romania, Storbritannia
Charles University, Czech Republic

Fullført

Effekt av metformin på treningsindusert lipolyse

Diabetes mellitus, type 2

Tsjekkia
Hoffmann-La Roche

Fullført

En studie av Aleglitazar i kombinasjon med metformin hos pasienter med type 2 diabetes mellitus som er utilstrekkelig kontrollert med metformin alene

Diabetes mellitus type 2

Forente stater, Mexico, Argentina
Milton S. Hershey Medical Center

Avsluttet

Metformin for behandling av prematur pubarche hos jenter

Prematur Pubarche

Forente stater
Hadassah Medical Organization

Tilbaketrukket

Open-label Crossover Metformin Gum Versus Tablet hos friske frivillige

Sunn

Israel
German Diabetes Center
Yale University

Påmelding etter invitasjon

"Levers rolle for interorganmetabolsk krysstale ved type 2-diabetes"

Type 2 diabetes

Tyskland
Woman's
Pfizer; American Cancer Society, Inc.; Our Lady of the Lake Regional Medical...

Tilbaketrukket

Metforminbruk for å redusere forskjeller i nylig diagnostisert brystkreft (METBC)

Insulinresistens | Brystkreftstadiet | Raseskjevhet

Forente stater

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus

Studieoversikt

Status

Forhold

Intervensjon / Behandling

Studietype

Registrering (Faktiske)

Fase

Kontakter og plasseringer

Studiesteder

Deltakelseskriterier

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

Tar imot friske frivillige

Kjønn som er kvalifisert for studier

Beskrivelse

Studieplan

Hvordan er studiet utformet?

Designdetaljer

Hva måler studien?

Primære resultatmål

Resultatmål

Sekundære resultatmål

Resultatmål

Samarbeidspartnere og etterforskere

Sponsor

Publikasjoner og nyttige lenker

Generelle publikasjoner

Hjelpsomme linker

Studierekorddatoer

Studer hoveddatoer

Studiestart

Primær fullføring (Faktiske)

Studiet fullført (Faktiske)

Datoer for studieregistrering

Først innsendt

Først innsendt som oppfylte QC-kriteriene

Først lagt ut (Anslag)

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

Siste oppdatering sendt inn som oppfylte QC-kriteriene

Sist bekreftet

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

IPD-planbeskrivelse

Studiedata/dokumenter

Kliniske studier på Diabetes mellitus, type 2

Kliniske studier på metformin

Søk i lignende forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

CROs by country

CROs in Ethiopia

Forhold

Sjeldne sykdommer

Legemiddelintervensjoner

Kosttilskudd

Sponsor / samarbeidspartnere

Steder